(Q33457767)

26 July 2017

title

Diagnosis and management of small intestinal bacterial overgrowth (English)

1 reference

small intestinal bacterial overgrowth

26 July 2017

main subject

0 references

author name string

Matthew Bohm

series ordinal

1

1 reference

26 July 2017

Robert M Siwiec

series ordinal

2

1 reference

26 July 2017

John M Wo

series ordinal

3

1 reference

26 July 2017

publication date

24 April 2013

1 reference

Nutrition in Clinical Practice

26 July 2017

published in

1 reference

26 July 2017

volume

28

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

289-299

1 reference

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal length: a factor essential for gut adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Food choice as a key management strategy for functional gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Intestinal bacterial overgrowth during chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Intestinal microbiota in functional bowel disorders: a Rome foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

The pathogenesis of gastrointestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Patterns and scales in gastrointestinal microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Review article: Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Duodenal bacterial overgrowth during treatment in outpatients with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Effects of long-term PPI treatment on producing bowel symptoms and SIBO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Omeprazole induces altered bile acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Diagnosis and management of adult patients with chronic intestinal pseudoobstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

A 14-day elemental diet is highly effective in normalizing the lactulose breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal bacterial overgrowth recurrence after antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small bowel bacterial overgrowth in subjects living in residential care homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestinal bacterial overgrowth in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613485882

21 January 2018

Identifiers

DOI

10.1177/0884533613485882

1 reference

26 July 2017

1 reference